MarginsXMarginsX
Home › Markets › Health Care › MBX

MBX Biosciences Inc. (MBX)

MBX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$53.12
-5.04% on the day
Market cap
$2.6B
Mid cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerMBX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2024
SEC CIK0001776111
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
20.2 months
$161.7M cash at September 30, 2026
Share count, 1 year
+10.6%
2025-11-03 to 2026-11-05
Going-concern doubt
No
10-Q filed November 9, 2026
Insider net buying, 12 months
-$1.7M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-09
Cash and burn$161.7M cash; operating cash flow -$24.0M a quarter.Report 2026-09-30
Shares outstanding49,656,265 (2026-11-05); 44,902,302 a year earlier.Cover page 2026-11-05
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-03-12
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Indianapolis, Indiana, United StatesPCAOB Form AP 2026-03-25
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.1M, sold $2.7M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$62.4M-$34.9M$161.7MNo debt tagsNeeds four quarters10-Q 2026-11-09
Q2 2026
2026-06-30
Not filed-$37.1M-$22.6M$54.1MNo debt tagsNeeds four quarters10-Q 2026-11-09
Q1 2026
2026-03-31
Not filed-$23.5M-$20.2M$45.2MNo debt tagsNeeds four quarters10-Q 2026-11-09
Q4 2025
2025-12-31
Not filed-$22.1M-$18.3M$75.3MNo debt tagsNeeds four quarters10-Q 2026-11-09
Q3 2025
2025-09-30
Not filed-$21.6M-$21.5M$223.1MNo debt tagsNeeds four quarters10-Q 2026-11-09
Q2 2025
2025-06-30
Not filed-$19.4M-$17.4M$39.8MNo debt tagsNeeds four quarters10-Q 2026-11-09
Q1 2025
2025-03-31
Not filed-$23.9M-$22.7M$29.9MNo debt tagsNeeds four quarters10-Q 2026-11-09
Q4 2024
2024-12-31
Not filed-$15.6M-$16.0M$49.4MNo debt tagsNeeds four quarters10-K 2026-03-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-03-12
Latest annual report10-K2026-03-12
Latest quarterly / interim10-Q2026-11-09
Latest current report8-K2026-11-09
Latest proxyDEFA14A2026-05-08

Source: SEC EDGAR submissions feed, 238 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+8.9%
1 month+14.2%
3 months-16.6%
Year to date+77.4%
1 year+132.4%
From 52-week high-20.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ZLABZai Lab Limited$23.47-4.59%$2.6B
XNCRXencor Inc.$35.40-4.56%$2.7B
HCMHUTCHMED (China) Limited$14.73-1.14%$2.6B
VCREVicore Pharma Holding AB$10.16-1.93%$2.9B
RCUSArcus Biosciences Inc.$16.86-3.27%$2.4B
IDYAIDEAYA Biosciences Inc.$30.36-4.62%$2.9B
NAMSNewAmsterdam Pharma Company N.V.$19.46-3.38%$2.3B
TLXTelix Pharmaceuticals Limited$8.92-3.36%$3.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier